BOVESPA:HAPV3

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Hapvida Participações e Investimentos

Executive Summary

Hapvida Participações e Investimentos S.A., together with its subsidiaries, operates in the healthcare sector in Brazil. More Details


Snowflake Analysis

Excellent balance sheet with moderate growth potential.

Share Price & News

How has Hapvida Participações e Investimentos's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: HAPV3 is more volatile than 75% of BR stocks over the past 3 months, typically moving +/- 7% a week.

Volatility Over Time: HAPV3's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of BR stocks.


Market Performance


7 Day Return

4.2%

HAPV3

15.2%

BR Healthcare

-0.7%

BR Market


1 Year Return

39.3%

HAPV3

48.5%

BR Healthcare

0.8%

BR Market

Return vs Industry: HAPV3 underperformed the BR Healthcare industry which returned 48.5% over the past year.

Return vs Market: HAPV3 exceeded the BR Market which returned 0.8% over the past year.


Shareholder returns

HAPV3IndustryMarket
7 Day4.2%15.2%-0.7%
30 Day17.8%28.2%4.9%
90 Day40.6%67.1%16.8%
1 Year40.0%39.3%49.6%48.5%3.5%0.8%
3 Yearn/a180.1%156.0%54.4%37.8%
5 Yearn/a747.6%622.1%219.0%164.3%

Long-Term Price Volatility Vs. Market

How volatile is Hapvida Participações e Investimentos's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Hapvida Participações e Investimentos undervalued compared to its fair value and its price relative to the market?

73.69x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: HAPV3 (R$17.92) is trading above our estimate of fair value (R$7.14)

Significantly Below Fair Value: HAPV3 is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: HAPV3 is poor value based on its PE Ratio (73.7x) compared to the BR Healthcare industry average (36.8x).

PE vs Market: HAPV3 is poor value based on its PE Ratio (73.7x) compared to the BR market (17.1x).


Price to Earnings Growth Ratio

PEG Ratio: HAPV3 is poor value based on its PEG Ratio (3.6x)


Price to Book Ratio

PB vs Industry: HAPV3 is overvalued based on its PB Ratio (8.5x) compared to the BR Healthcare industry average (5.8x).


Next Steps

Future Growth

How is Hapvida Participações e Investimentos forecast to perform in the next 1 to 3 years based on estimates from 10 analysts?

20.6%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: HAPV3's forecast earnings growth (20.6% per year) is above the savings rate (9.9%).

Earnings vs Market: HAPV3's earnings (20.6% per year) are forecast to grow slower than the BR market (27.3% per year).

High Growth Earnings: earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: HAPV3's revenue (14.8% per year) is forecast to grow faster than the BR market (10.4% per year).

High Growth Revenue: HAPV3's revenue (14.8% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: HAPV3's Return on Equity is forecast to be low in 3 years time (18.3%).


Next Steps

Past Performance

How has Hapvida Participações e Investimentos performed over the past 5 years?

15.1%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: HAPV3 has high quality earnings.

Growing Profit Margin: HAPV3's current net profit margins (10.9%) are lower than last year (16.3%).


Past Earnings Growth Analysis

Earnings Trend: HAPV3's earnings have grown by 15.1% per year over the past 5 years.

Accelerating Growth: HAPV3's earnings growth over the past year (3%) is below its 5-year average (15.1% per year).

Earnings vs Industry: HAPV3 earnings growth over the past year (3%) exceeded the Healthcare industry -0.7%.


Return on Equity

High ROE: HAPV3's Return on Equity (11.5%) is considered low.


Next Steps

Financial Health

How is Hapvida Participações e Investimentos's financial position?


Financial Position Analysis

Short Term Liabilities: HAPV3's short term assets (R$3.4B) exceed its short term liabilities (R$1.9B).

Long Term Liabilities: HAPV3's short term assets (R$3.4B) exceed its long term liabilities (R$3.4B).


Debt to Equity History and Analysis

Debt Level: HAPV3's debt to equity ratio (26.3%) is considered satisfactory.

Reducing Debt: HAPV3's debt to equity ratio has increased from 0.05% to 26.3% over the past 5 years.

Debt Coverage: HAPV3's debt is well covered by operating cash flow (58.2%).

Interest Coverage: HAPV3's interest payments on its debt are well covered by EBIT (10.2x coverage).


Balance Sheet


Next Steps

Dividend

What is Hapvida Participações e Investimentos's current dividend yield, its reliability and sustainability?

0.53%

Forecast Dividend Yield


Dividend Yield vs Market

Notable Dividend: Unable to evaluate HAPV3's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate HAPV3's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if HAPV3's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if HAPV3's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of HAPV3's dividend in 3 years as they are not forecast to pay a notable one for the BR market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

4.8yrs

Average management tenure


CEO

Jorge Fontoura Pinheiro de Lima

20yrs

Tenure

Mr. Jorge Fontoura Pinheiro Koren de Lima has been a Director at Hapvida Participações e Investimentos S.A. since February 09, 2018 and has also been its CEO since 2001. He is currently taking the “Advance...


Leadership Team

NamePositionTenureCompensationOwnership
Jorge Fontoura Pinheiro de Lima
CEO & Director20yrsno datano data
Candido Pinheiro de Koren Lima
no datano data0%
R$ 0
Bruno de Oliveira
CFO & Investors Relation4.67yrsno datano data
Alain Benvenuti
Chief Operating Officer4yrsno datano data
Candido Pinheiro de Lima
Chief Commercial & Relationship Officerno datano datano data
João Schneider
Corporate Director of Audit10.08yrsno datano data
Marcos Peixinho
Executive Director of Human Resources3.33yrsno datano data
Gustavo Chaves de Oliveira
Chief Strategy Officer4.83yrsno datano data
Guilherme Nahuz
Investor Relations Directorno datano datano data
Candido Pinheiro Koren de Lima
no datano data0%
R$ 0

4.8yrs

Average Tenure

Experienced Management: HAPV3's management team is considered experienced (4.8 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Jorge Fontoura Pinheiro de Lima
CEO & Director20yrsno datano data
Candido Pinheiro de Lima
Chief Commercial & Relationship Officerno datano datano data
Márcio Luiz Simões Utsch
Independent Director1.5yrsno datano data
Geraldo Mattos
Independent Director2.92yrsno datano data
Wilson Filho
Independent Director4.42yrsno datano data
Candido Pinheiro de Lima
Chairman of the Board of Directors2.92yrsno datano data
Guilherme Filho
Member of the Advisory Councilno datano datano data
Igor Xavier Lima
Independent Director0.25yrno datano data

2.9yrs

Average Tenure

Experienced Board: HAPV3's board of directors are not considered experienced ( 2.9 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Hapvida Participações e Investimentos S.A.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Hapvida Participações e Investimentos S.A.
  • Ticker: HAPV3
  • Exchange: BOVESPA
  • Founded: 1979
  • Industry: Managed Health Care
  • Sector: Healthcare
  • Market Cap: R$64.528b
  • Shares outstanding: 3.71b
  • Website: https://ri.hapvida.com.br

Number of Employees


Location

  • Hapvida Participações e Investimentos S.A.
  • Rua Dona Leopoldina, 1150
  • Centro
  • Fortaleza
  • Ceará
  • Brazil

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
HAPV3BOVESPA (Bolsa de Valores de Sao Paulo)YesCommon SharesBRBRLApr 2018

Biography

Hapvida Participações e Investimentos S.A., together with its subsidiaries, operates in the healthcare sector in Brazil. The company offers health and dental insurance plans. It also provides medical and p...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/01/21 22:01
End of Day Share Price2021/01/21 00:00
Earnings2020/09/30
Annual Earnings2019/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.